These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

897 related items for PubMed ID: 14517844

  • 21. c-FLIP expression in bladder urothelial carcinomas: its role in resistance to Fas-mediated apoptosis and clinicopathologic correlations.
    Korkolopoulou P, Goudopoulou A, Voutsinas G, Thomas-Tsagli E, Kapralos P, Patsouris E, Saetta AA.
    Urology; 2004 Jun; 63(6):1198-204. PubMed ID: 15183989
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. The Fas counterattack in vivo: apoptotic depletion of tumor-infiltrating lymphocytes associated with Fas ligand expression by human esophageal carcinoma.
    Bennett MW, O'Connell J, O'Sullivan GC, Brady C, Roche D, Collins JK, Shanahan F.
    J Immunol; 1998 Jun 01; 160(11):5669-75. PubMed ID: 9605174
    [Abstract] [Full Text] [Related]

  • 24. Expression of Fas and Fas ligand in esophageal tissue mucosa and carcinomas.
    Kase S, Osaki M, Adachi H, Kaibara N, Ito H.
    Int J Oncol; 2002 Feb 01; 20(2):291-7. PubMed ID: 11788891
    [Abstract] [Full Text] [Related]

  • 25. Human lung carcinomas express Fas ligand.
    Niehans GA, Brunner T, Frizelle SP, Liston JC, Salerno CT, Knapp DJ, Green DR, Kratzke RA.
    Cancer Res; 1997 Mar 15; 57(6):1007-12. PubMed ID: 9067260
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Quantitation of Fas and Fas ligand gene expression in human ovarian, cervical and endometrial carcinomas using real-time quantitative RT-PCR.
    Das H, Koizumi T, Sugimoto T, Chakraborty S, Ichimura T, Hasegawa K, Nishimura R.
    Br J Cancer; 2000 May 15; 82(10):1682-8. PubMed ID: 10817504
    [Abstract] [Full Text] [Related]

  • 28. Fas ligand-positive membranous vesicles isolated from sera of patients with oral cancer induce apoptosis of activated T lymphocytes.
    Kim JW, Wieckowski E, Taylor DD, Reichert TE, Watkins S, Whiteside TL.
    Clin Cancer Res; 2005 Feb 01; 11(3):1010-20. PubMed ID: 15709166
    [Abstract] [Full Text] [Related]

  • 29. Expression of Bcl-2 in lung neuroendocrine tumours: comparison with p53.
    Wang DG, Johnston CF, Sloan JM, Buchanan KD.
    J Pathol; 1998 Mar 01; 184(3):247-51. PubMed ID: 9614375
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Fas-related apoptosis in gastric adenocarcinoma.
    Lim SC.
    Oncol Rep; 2003 Mar 01; 10(1):57-63. PubMed ID: 12469145
    [Abstract] [Full Text] [Related]

  • 32. Defective expression of FasL and Bax in human lung cancer.
    Badillo-Almaraz I, Badillo-Salas C, Villalobos R, Avalos-Díaz E, Herrera-Esparza R.
    Clin Exp Med; 2003 Sep 01; 3(2):106-12. PubMed ID: 14598185
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Restoration of p53 expression sensitizes human papillomavirus type 16 immortalized human keratinocytes to CD95-mediated apoptosis.
    Aguilar-Lemarroy A, Gariglio P, Whitaker NJ, Eichhorst ST, zur Hausen H, Krammer PH, Rösl F.
    Oncogene; 2002 Jan 10; 21(2):165-75. PubMed ID: 11803460
    [Abstract] [Full Text] [Related]

  • 38. Soluble Fas and Fas ligand provide new information on metastasis and response to chemotherapy in SCLC patients.
    Shimizu M, Kondo M, Ito Y, Kume H, Suzuki R, Yamaki K.
    Cancer Detect Prev; 2005 Jan 10; 29(2):175-80. PubMed ID: 15829378
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 45.